612 research outputs found

    A Passive Monitoring System in Assisted Living Facilities: 12-Month Comparative Study

    Get PDF
    The GE QuietCare® passive monitoring system uses advanced motion sensor technology that learns the daily living patterns of senior community residents and sends alerts when certain out-of-the-ordinary events occur. This study compared falls, hospitalizations, care level changes, and resident attrition between two similar assisted living facilities where one facility adopted the QuietCare® monitoring system and the other did not over a 12-month period. Average falls per week were significantly lower in the QuietCare® facility than the control facility. There was also a trend toward fewer weekly hospitalizations in the QuietCare® facility. There was higher resident retention at the QuietCare® facility. This study provides evidence of direct benefits to both the resident and the facility for the use of QuietCare®. There was a significant reduction in the number of falls, as well as a general facility performance improvement measured by care level consistency and higher resident retention rates

    Angina: contemporary diagnosis and management

    Get PDF
    No abstract available

    Central monitoring system for ambient assisted living

    Get PDF
    Smart homes for aged care enable the elderly to stay in their own homes longer. By means of various types of ambient and wearable sensors information is gathered on people living in smart homes for aged care. This information is then processed to determine the activities of daily living (ADL) and provide vital information to carers. Many examples of smart homes for aged care can be found in literature, however, little or no evidence can be found with respect to interoperability of various sensors and devices along with associated functions. One key element with respect to interoperability is the central monitoring system in a smart home. This thesis analyses and presents key functions and requirements of a central monitoring system. The outcomes of this thesis may benefit developers of smart homes for aged care

    Umsetzung von Lungenkrebs-Screening

    Get PDF
    Two large-scale and sufficiently powered randomized-controlled trials and several smaller European trials have provided evidence on the effectiveness and feasibility of screening for lung cancer by means of low-dose computed tomography (LDCT) for a high-risk population. These findings support the implementation and upscaling of lung cancer screening to nationwide programs in Germany and the rest of Europe. At the same time, lung cancer screening efficiency can still be improved by further personalization and risk stratification, to maintain or improve the benefits while substantially reducing harms and costs (such as CT examinations needed, false-positive results and subsequent follow-up procedures). This review discusses the most pressing issues, such as the further development of adequate recruitment methods, risk-based eligibility and screening intervals, improved nodule detection and management, integrated smoking cessation programs, and a unified approach of the early detection of smoking-related diseases. The 4-IN-THE-LUNG-RUN (acronym for: Towards INdividually tailored INvitations, screening INtervals and INtegrated co-morbidity reducing strategies in lung cancer screening) is the first European multi-centred implementation trial on volume CT lung cancer screening amongst 24,000 high-risk subjects, across five countries. Germany is one of the participating countries, represented by the Deutsche Krebsforschungszentrum and the Universitätsklinikum (Ruhrlandklinik) Essen. The trial is expected to provide answers to the remaining issues, so that a high-quality screening program can be made accessible to those who might benefit most from lung cancer screening while keeping individual and societal harms at a minimum.</p

    A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia

    Get PDF
    Although dementia research has been dominated by Alzheimer's disease (AD), most dementia in older people is now recognised to be due to mixed pathologies, usually combining vascular and AD brain pathology. Vascular cognitive impairment (VCI), which encompasses vascular dementia (VaD) is the second most common type of dementia. Models of VCI have been delayed by limited understanding of the underlying aetiology and pathogenesis. This review by a multidisciplinary, diverse (in terms of sex, geography and career stage), cross-institute team provides a perspective on limitations to current VCI models and recommendations for improving translation and reproducibility. We discuss reproducibility, clinical features of VCI and corresponding assessments in models, human pathology, bioinformatics approaches, and data sharing. We offer recommendations for future research, particularly focusing on small vessel disease as a main underpinning disorder
    • …
    corecore